Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human SEMA3D ELISA Kit (AC3421)
Cat.#: ASET-2010
Specifications
Description Human SEMA3D ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SEMA3D concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.052 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2525 Mouse Acetylcholinesterase ELISA Kit (AC3936) Quantitative inquiry ASET-1635 Mouse CX3CR1 ELISA Kit (AC3046) Quantitative inquiry ASET-1639 Human Ataxin 1 ELISA Kit (AC3050) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1743 Human TMPRSS2 ELISA Kit (AC3154) Quantitative inquiry ASET-1099 Human FTO ELISA Kit (AC2510) Quantitative inquiry ASET-1495 Mouse Dopamine Receptor D1 ELISA Kit (AC2906) Quantitative inquiry ASET-1839 Human Chordin ELISA Kit (AC3250) Quantitative inquiry ASET-1182 Human CDK5 ELISA Kit (AC2593) Quantitative inquiry ASET-2373 Mouse Nurr1 ELISA Kit (AC3784) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket